Effect of the endothelin receptor inhibitor (bosentan) on right ventricular myocardial performance index and aortic stiffness in patients with systemic sclerosis and pulmonary hypertension

被引：0
|
作者：
Moyssakis, I [1 ]
Gialafos, E [1 ]
Papadopoulos, D [1 ]
Vassiliou, V [1 ]
Votteas, V [1 ]
Sfikakis, R [1 ]
机构：
[1] Laikon Gen Hosp, Athens, Greece
来源：
JOURNAL OF HYPERTENSION | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S344 / S345
页数：2
相关论文
共 50 条
  • [41] Use of the myocardial performance index to assess right ventricular function and outcome in infants with persistent pulmonary hypertension
    Eidem, BW
    Cetta, F
    Butler, J
    Suzuki, C
    CIRCULATION, 2000, 102 (18) : 742 - 742
  • [42] Right Ventricular Tissue Doppler Myocardial Performance Index in Children with Pulmonary Hypertension: Relation to Invasive Hemodynamics
    Richard M. Friesen
    Michal Schäfer
    Dale A. Burkett
    Courtney J. Cassidy
    D. Dunbar Ivy
    Pei-Ni Jone
    Pediatric Cardiology, 2018, 39 : 98 - 104
  • [43] Right ventricular function during inhaled nitric oxide test in systemic sclerosis patients with pulmonary hypertension
    Plazak, Wojciech
    Podolec, Piotr
    Gryga, Krzysztof
    Wilisowska, Joanna
    Musial, Jacek
    Tracz, Wieslawa
    ACTA CARDIOLOGICA, 2007, 62 (06) : 646 - 646
  • [44] Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension Relative Contribution of Fibrosis and Myofibril Stiffness
    Rain, Silvia
    Andersen, Stine
    Najafi, Aref
    Schultz, Jacob Gammelgaard
    Bos, Denielli da Silva Goncalves
    Handoko, M. Louis
    Bogaard, Harm-Jan
    Vonk-Noordegraaf, Anton
    Andersen, Asger
    van der Velden, Jolanda
    Ottenheijm, Coen A. C.
    de Man, Frances S.
    Circulation-Heart Failure, 2016, 9 (07)
  • [45] Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis
    John Varga
    Current Rheumatology Reports, 2003, 5 (2) : 145 - 146
  • [46] The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
    Krum, H
    Viskoper, RJ
    Lacourciere, Y
    Budde, M
    Charlon, V
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12): : 784 - 790
  • [47] The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock
    Wanecek, M
    Rudehill, A
    Hemsen, A
    Lundberg, JM
    Weitzberg, E
    CRITICAL CARE MEDICINE, 1997, 25 (05) : 848 - 857
  • [48] Improvement of vascular endothelial function using the oral endothelin receptor antagonist Bosentan in patients with systemic sclerosis
    Sfikakis, P. P.
    Papamichael, C.
    Starnatelopoulos, K. S.
    Tousoulis, D.
    Fragiadaki, K. G.
    Katsichti, P.
    Stefanadis, C.
    Mavrikakis, M.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1985 - 1993
  • [49] Effects of endothelin receptor antagonist (ERA) bosentan on myocardial glucose metabolism in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
    Mitsakis, Periklis
    Yerly, Patrick
    Dunet, Vincent
    Deshayes, Emmanuel
    Aebsicher, Nicole
    Prella, Maura
    Prior, John
    Aubert, John-David
    Laurent, Nicod
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [50] Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension
    Coksevim, Metin
    Cerik, Idris Bugra
    Yenercag, Mustafa
    Kocasari, Ahmet Onur
    Yavuzbilge, Gokhan
    Polat, Musa
    Meric, Murat
    Ozgen, Metin
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (10): : 2191 - 2197
12345